Introduction
============

Genome wide association studies of several distinct human cohorts have pointed out variations in the *GRID1* gene linked with schizophrenia and bipolar disorder.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^ Likewise, *GRID1* knockout mice exhibit endophenotypes relevant for these pathologies and have been proposed as a model of schizophrenia and depression co-morbidity.^[@bib5],\ [@bib6],\ [@bib7],\ [@bib8]^ *GRID1* encodes GluD1, which forms with GluD2 the delta family of ionotropic glutamate receptors.^[@bib9]^ GluDs have remained orphan of a pore-opening ligand since their cloning, raising doubts on their function as ion channels,^[@bib9],\ [@bib10],\ [@bib11]^ until the recent demonstration that GluD2 channel opening is triggered by mGlu1 activation through the canonical Gq/phospholipase C/protein kinase C pathway, and plays a key role in slow glutamatergic transmission in the cerebellum.^[@bib12],\ [@bib13]^ In support of this function, native GluDs physically interact with mGlu1 and mGlu5 metabotropic glutamate receptors of the group I (mGlu1/5).^[@bib14],\ [@bib15]^ GluD1 is widely expressed in the brain and largely predominates over GluD2 outside the cerebellum.^[@bib16],\ [@bib17]^ GluD1 is localized at the postsynaptic density of excitatory synapses and its expression increases during postnatal development,^[@bib16],\ [@bib17]^ consistent with a role in glutamatergic transmission in the adult.

Alterations of dopamine (DA) and glutamate neurotransmission are critical factors in the physiopathology of schizophrenia.^[@bib18]^ The main source of DA in the brain originates in midbrain neurons of the substantia nigra (SN) and ventral tegmental area (VTA). The firing of these neurons consists in single spikes, but also in bursts of action potentials^[@bib19]^ that enhance DA release and have important behavioral correlates.^[@bib20],\ [@bib21]^ Accordingly, an imbalance between these two firing modes is thought to be a key factor in the physiopathology of schizophrenia^[@bib22],\ [@bib23]^ and is linked to alterations of brain circuits and behaviors in a mouse model of schizophrenia.^[@bib24]^ Interestingly, DA neurons of both the SN and the VTA express mGlu1/5 receptors,^[@bib25]^ whose activation promotes their burst firing,^[@bib26],\ [@bib27],\ [@bib28]^ and exhibit a prominent slow excitatory postsynaptic current (EPSC), which is blocked by mGlu1/5 antagonists.^[@bib29],\ [@bib30]^ These observations suggest that GluD1 may play a role in slow glutamatergic transmission onto DA neurons, and in the firing pattern of these neurons.

The present study examines the functional coupling between mGlu1/5 and GluD1 and its role in DA neurons using a combination of electrophysiology, molecular inactivation and histochemistry. We first tested the ability of mGlu1 to gate GluD1 channels in a heterologous expression system. We then examined the expression of GluD1 mRNA and protein in DA neurons. Finally, we probed the role of GluD1 in the slow EPSC and the firing pattern of DA neurons in midbrain slices of wild type (WT) and *GRID1* knockout mice and *in vivo*. The results indicate that mGlu1/5 activation triggers the opening of GluD1 channels, which are key determinants of the slow EPSC and the burst firing of DA neurons.

Materials and methods
=====================

Detailed materials and methods are provided as [Supplementary Information](#sup1){ref-type="supplementary-material"}

Plasmids and viruses
--------------------

The plasmids encoding rat mGlu1a-YFP,^[@bib31]^ mGlu5a-Venus,^[@bib32]^ mouse GluD1 (Source Bioscience, Nottingham, UK) or human 5-HT2C^[@bib33]^ under the control of a cytomegalovirus promoter were transfected in human embryonic kidney cells (HEK293T line) using the calcium phosphate precipitation method. Sindbis viruses (or lentiviruses) expressing both the GluD1^V617R^ mutant and green fluorescent protein (GFP), or GFP alone, were constructed from pSinEGdsp^[@bib34]^ (or pLV-PGK-β2-ires-GFP-WPRE,^[@bib35]^ pLV-PDGF-lox-mCherry-lox-β2^[@bib36]^), or already described (pLV-PGK-GFP,^[@bib35]^ pLV-PDGF-lox-mCherry-lox-GFP^[@bib37]^). Recombinant pseudo-virions were produced as described^[@bib35],\ [@bib38]^ and stereotaxically injected in the SN/VTA of WT or DAT-Cre^[@bib39]^ mice 14--24 h (Sindbis) or 4--6 weeks (lentivirus) before electrophysiological recordings.

Mice and electrophysiological recordings
----------------------------------------

Animal breeding and killing were performed in accordance to European Commission guidelines and French legislation (2010/63/UE) and procedures were approved by the French Ministry of Research (Agreement \# 01479.01). GluD1 knockout,^[@bib5]^ GluD2 Hotfoot (HO)^[@bib40]^ and DAT-Cre^[@bib39]^ mice were genotyped as described.^[@bib16],\ [@bib39]^ Homozygous GluD1-knockout mice were obtained from breeding heterozygous parents. WT mice were purchased from Janvier Labs (Le Genest-Saint-Isle, France). All mice had C57BL/6 background. Whole-cell electrophysiological recordings in midbrain slices from P14--P18 mice, and *in vivo* juxtacellular recordings in 6--12 week-old anesthetized mice were performed using standard procedures.

Single-cell real-time-PCR and immunochemistry
---------------------------------------------

Single-cell real-time PCR (RT-PCR) after patch-clamp was performed as described^[@bib41],\ [@bib42]^ using primer pairs given in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. We used standard procedures for immunocyto-, immunohisto-chemistry and immunoprecipitation. Immunohistochemical reactions at the electron microscopic level were carried out using the post-embedding immunogold method as described.^[@bib43]^

Statistical analyses
--------------------

Results are given as mean±s.e.m. *In vitro* data were analyzed using Mann--Whitney or Wilcoxon rank signed nonparametric tests. Differences were considered significant if *P*\<0.05. In the *in vivo* section, three-group comparisons were performed using a Student *t*-test with Bonferroni correction, and two group comparisons were performed using Student *t*-test (if *n*\>30) or Wilcoxon rank signed test (if *n*\<30) with significance set at *P*\<0.05.

Results
=======

The activation of mGlu1/5 triggers the opening of GluD1 channels in a heterologous expression system
----------------------------------------------------------------------------------------------------

We tested the existence of a functional coupling between mGlu1 and GluD1 in HEK 293 cells transfected with plasmids encoding GluD1 and an mGlu1-YFP fusion protein. Expression of these proteins, separately or together, resulted in their correct targeting to the plasma membrane ([Figure 1f](#fig1){ref-type="fig"}, [Supplementary Figures S1 and S2](#sup1){ref-type="supplementary-material"}). Local application of the mGlu1/5 agonist 3,5-dihydroxyphenylglycine (DHPG, 100 μ[M]{.smallcaps}) on cells expressing both mGlu1 and GluD1 induced a slow and reversible inward current (*I*~DHPG~, 131±31 pA, *n*=13; [Figure 1a](#fig1){ref-type="fig"}). Similar results were obtained on HEK cells co-transfected with plasmids encoding mGlu5-Venus and GluD1 (*I*~DHPG~, 78±7 pA, *n*=9; not shown). The *I*~DHPG~ observed in mGlu1+GluD1-expressing cells was almost abolished in the presence of the mGlu1/5 antagonist 1-aminoindan-1,5-dicarboxylic acid (AIDA, 150 μ[M]{.smallcaps}; 7±5 pA, *n*=5, *P*\<0.03; not shown), indicating that this current was triggered by activation of mGlu1. No DHPG-induced current was observed in cells expressing either mGlu1 (*n*=15) or GluD1 (*n*=6) alone ([Figure 1a](#fig1){ref-type="fig"}), attesting to the critical dependence of the *I*~DHPG~ on both proteins. The mutual requirement of mGlu1/5 and GluD1 to generate currents was further tested by stimulating other Gq-coupled receptors in GluD1-expressing HEK cells. No response was observed upon stimulation of the endogenous muscarinic M3 receptor^[@bib44],\ [@bib45],\ [@bib46]^ by carbachol (100 μ[M]{.smallcaps}) in DHPG-responsive HEK cells co-expressing mGlu1 and GluD1 (*n*=5, *I*~DHPG~: 80±19 pA; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Similarly, application of the 5-HT2C serotonin receptor agonist 2,5-dimethoxy-4-iodoamphetamine (50 μ[M]{.smallcaps}) failed to induce appreciable response in HEK cells co-expressing 5-HT2C and GluD1 (1.7±2.6 pA, *n*=10; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). These results are in line with the observation that PKC activation is not sufficient to elicit GluD2 currents,^[@bib13]^ and suggest that mGlu1/5-GluD coupling in HEK cells may rely on their physical interaction, which is documented for native receptors in the brain.^[@bib14],\ [@bib15]^ Indeed, we found that antibodies against either GluD1, mGlu1 or mGlu5 co-immunoprecipitated recombinant mGlu1/5 and GluD1 expressed in HEK cells ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). These results indicate that the current caused by the activation of mGlu1/5 in HEK cells relies on the physical interaction of mGlu1/5 receptors with GluD1.

We next examined the involvement of the GluD1 channel pore in the mGlu1-dependent current by characterizing its biophysical and pharmacological properties. The current--voltage (*I--V*) relationship of the *I*~DHPG~ exhibited a reversal potential around 0 mV and a marked inward rectification at positive potentials (*n*=8, see example in [Figure 1b](#fig1){ref-type="fig"}). This voltage-dependence is similar to that reported for GluD2-mediated currents.^[@bib12],\ [@bib47],\ [@bib48]^ We also tested the effect of two inhibitors of GluD1 and GluD2, the calcium-permeable AMPA receptor-channel blocker naphtyl-acetyl spermine (NASPM) and D-serine.^[@bib12],\ [@bib47],\ [@bib49],\ [@bib50],\ [@bib51]^ NASPM (100 μ[M]{.smallcaps}) and D-serine (10 m[M]{.smallcaps}) reduced the *I*~DHPG~ by 86±4% (*n*=5, *P*\<0.001) and 42±8% (*n*=5, *P*\<0.05), respectively ([Figures 1c and d](#fig1){ref-type="fig"}), consistent with the involvement of GluD1 channels. To assess permeation of the *I*~DHPG~ through GluD1 channels, we used a dominant-negative GluD1 dead pore mutant obtained by a valine to arginine substitution at position 617 (GluD1^VR^), as described for GluD2 and AMPA/kainate receptor subunits.^[@bib12],\ [@bib52],\ [@bib53]^ We verified the correct targeting of GluD1^VR^ to the plasma membrane and its co-immunoprecipitation with mGlu1/5 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). No *I*~DHPG~ was observed in cells co-expressing mGlu1 and GluD1^VR^ (*n*=8). Moreover, increasing the amount of GluD1^VR^ plasmid in co-transfection with mGlu1 and WT GluD1 gradually decreased *I*~DHPG~ amplitude (*n*⩾4 for each GluD1^VR^/GluD1^WT^ ratio tested, [Figure 1e](#fig1){ref-type="fig"}). These results indicate that mGlu1/5 activation triggers the opening of the GluD1 channel in HEK cells.

GluD1 is co-expressed with mGlu1/5 in DA neurons
------------------------------------------------

Currents evoked by activation of mGlu1/5 in midbrain DA neurons of the SN pars compacta (SNc) and the VTA share biophysical properties with mGlu1/5-activated GluD currents in HEK cells and cerebellar Purkinje cells (see above and references [@bib12], [@bib29], [@bib30]). We thus probed the expression of GluD1 in DA neurons using anti-GluD1 together with anti-DA transporter (DAT) or anti-tyrosine hydroxylase (TH, the DA-synthesizing enzyme) immunohistochemistry. At the light microscopic level, we observed a diffuse expression of GluD1 in somata and processes of DAT-positive neurons in the SNc and VTA ([Figure 2a](#fig2){ref-type="fig"}). At higher magnification, GluD1 immunopositive puncta were observed at intracellular and putative plasma membrane locations of DAT-positive somata and dendritic shafts ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}), as described in the cerebellum.^[@bib17]^ Further examination at the electron microscopic level in the SNc revealed that immunogold particles for GluD1 were localized along the postsynaptic density of excitatory synapses in TH-positive neurons ([Figure 2b](#fig2){ref-type="fig"}). Quantitative analysis showed that most immunoparticles were found at postsynaptic sites (98.3%, *n*=339) and only few (1.7%, *n*=6) at presynaptic sites. Of the immunoparticles located at postsynaptic sites, 81.4% (*n*=276) were found in the plasma membrane of dendritic shafts, and 18.6% (*n*=63) at cytoplasmic site associated in intracellular membranes. Of the immunoparticles located in the plasma membrane, 80.1% (*n*=221) were found in the postsynaptic density of excitatory synapses, and 19.9% (*n*=55) along the extrasynaptic plasma membrane. GluD1 immunolabeling was absent in GluD1^−/−^ mice ([Figures 2a and b](#fig2){ref-type="fig"}), consistent with earlier observations.^[@bib16]^ These results show that GluD1 is expressed in DA neurons at excitatory postsynaptic sites, as found in other brain regions.^[@bib16],\ [@bib17]^

We next examined GluD1 expression in DA neurons of the SNc using patch-clamp recordings and single-cell RT-PCR in acute midbrain slices. We selected DA neurons based on their long duration action potentials (above 1.5 ms at half-width) and their spontaneous pacemaker firing at low rate (below 2 Hz at resting membrane potential, [Figure 2c](#fig2){ref-type="fig"}), which discriminate them from local GABAergic neurons.^[@bib54],\ [@bib55]^ The identity of recorded DA neurons was confirmed by *post hoc* TH immunostaining (*n*=122 TH-positive neurons out of 126 tested throughout this study, [Figure 2c](#fig2){ref-type="fig"}). We also verified the responsiveness of DA neurons to mGlu1/5 activation in our experimental conditions. Indeed, in the presence of ionotropic glutamate and GABA receptor antagonists (CNQX 10 μ[M]{.smallcaps}, APV 50 μ[M]{.smallcaps}, gabazine 10 μ[M]{.smallcaps}), we observed robust inward currents in response to DHPG application (100 μ[M]{.smallcaps}, 102±13 pA, *n*=33), and slow EPSCs (sEPSC) in response to bursts of local electrical stimulation (97±10 pA, *n*=27), as earlier described.^[@bib29],\ [@bib30]^ Both currents were almost abolished in the presence of AIDA (150 μ[M]{.smallcaps}; *I*~DHPG~: *n*=5, *P*\<0.05; sEPSC: *n*=7, *P*\<0.01; [Figures 2e and f](#fig2){ref-type="fig"}), consistent with the reported involvement of mGlu1/5 in these responses.^[@bib29],\ [@bib30]^ DA neurons identified by their electrophysiological properties were all TH-positive upon analysis by single-cell RT-PCR (*n*=28, [Figure 2d](#fig2){ref-type="fig"}), whereas mRNAs for the GABA synthesizing enzymes were only detected in11% (GAD65) and 21% (GAD67) of these cells. A majority of these DA neurons (93%) were positive for mGlu1 (64%) and/or mGlu5 (75%), in line with functional and immunohistochemical observations.^[@bib25]^ GluD1 expression was also detected with a high occurrence (86%) in this sample, in agreement with our above immunochemical data, whereas GluD2 occurrence was lower (57%), consistent with its low abundance in brain regions outside the cerebellum.^[@bib16]^ These results show that GluD1 is co-expressed with mGlu1/5 in DA neurons.

GluD1 channels mediate mGlu1/5-dependent currents in DA neurons
---------------------------------------------------------------

To test the involvement of GluD1 in mGlu1/5-gated currents of DA neurons, we investigated the effects of GluD1 deletion on the sEPSC and *I*~DHPG~ recorded in acute midbrain slices. We first compared fast EPSCs in DA neurons from WT and GluD1^−/−^ mice to rule out major alteration of excitatory synaptic inputs onto GluD1^−/−^ DA neurons. Fast EPSC amplitudes did not significantly differ between WT and GluD1^−/−^ cells (SNc: 91±12 pA (*n*=27) and 123±28 pA (*n*=17), respectively, *P*=0.5; VTA: 154±34 pA (*n*=12) and 280±71 pA (*n*=10), respectively, *P*=0.14). Moreover, AMPA and NMDA receptor-mediated components of fast EPSCs in SNc DA neurons were not significantly different in WT and GluD1^−/−^ mice (NMDA amplitude: 82±10 pA and 106±13 pA, AMPA/NMDA ratio: 3.1±0.6 and 2.6±0.3, NMDA decay time-constant: 69±7 ms and 77±6 ms, *n*=16 and 19, respectively, *P*⩾0.24; see [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). In contrast, we found that the sEPSC recorded in SNc DA neurons was strongly reduced in GluD1^−/−^ mice (13±5 pA, *n*=20) relatively to WT animals (97±12 pA, *n*=27; *P*\<0.001; [Figure 3a](#fig3){ref-type="fig"}). The *I*~DHPG~ of SNc DA neurons was also largely diminished in GluD1^−/−^ vs WT mice (16±7 pA, *n*=14 vs 102±13 pA, *n*=33; *P*\<0.001; [Figure 3b](#fig3){ref-type="fig"}). Conversely, mGlu1/5-gated currents in SNc DA neurons were not significantly altered in Hotfoot-Nancy mutant mice^[@bib40]^ (GluD2^HO/HO^) that bear a deletion of the GluD2 gene (sEPSC: 80±20 pA, *n*=7, *P*=0.46; *I*~DHPG~: 69±28 pA, *n*=8, *P*=0.55; [Figures 3a and b](#fig3){ref-type="fig"}), as expected from the low abundance of GluD2 in DA neurons. We further examined the involvement of GluD1 in the mGlu1/5-gated currents of DA neurons by recording their sEPSC in the VTA. Similar to our findings in the SNc, the sEPSC of VTA DA neurons recorded in WT mice (265±45 pA, *n*=12) was almost abolished in GluD1^−/−^ mice ([Figure 3c](#fig3){ref-type="fig"}), unmasking an outward current in half of the recorded cells (mean of GluD1^−/−^ cells: 26±22 pA outward, *n*=12; *P*\<0.001). These results show that mGlu1/5-gated currents in DA neurons critically rely on GluD1.

To evaluate the contribution of GluD1 channels to mGlu1/5-gated currents, we next characterized their pharmacological and biophysical properties in SNc DA neurons. The application of NASPM (100 μ[M]{.smallcaps}) strongly reduced both the sEPSC (by 82±5%, *n*=7, *P*\<0.001) and the *I*~DHPG~ (by 98±1%, *n*=9, *P*\<0.001, [Figure 3d](#fig3){ref-type="fig"}) of DA neurons, similar to NASPM effects on the GluD1 current in HEK cells. The *I--V* curves of mGlu1/5-gated currents in DA neurons have been earlier described^[@bib29],\ [@bib30]^ and resemble that of the GluD1 current in HEK cells. Indeed, we observed that the *I--V* curves of the sEPSC (*n*=8) and the *I*~DHPG~ (*n*=4) were both roughly linear with a reversal potential around 0 mV and exhibited inward rectification at positive potentials ([Figure 3e](#fig3){ref-type="fig"}), in agreement with previous reports.^[@bib29],\ [@bib30]^ Hence, the pharmacological and biophysical properties of mGlu1/5-gated currents in DA neurons point to the key contribution of GluD1 channels.

We assessed the dependence of mGlu1/5-gated currents on the GluD1 channel pore by co-expressing the dominant-negative GluD1^VR^ pore mutant and GFP in DA neurons through viral transfer with a Sindbis vector in the SNc of WT mice. We found that the sEPSC was largely reduced in DA neurons co-expressing GluD1^VR^ and GFP (9±2 pA, *n*=7) compared to DA neurons expressing GFP alone (110±20 pA, *n*=6, *P*\<0.001, [Figure 3f](#fig3){ref-type="fig"}). The *I*~DHPG~ was also hampered by GluD1^VR^ and GFP co-expression in DA neurons (34±21 pA, *n*=6) compared to DA neurons expressing GFP alone (103±22 pA, *n*=7, *P*\<0.03, [Figure 3f](#fig3){ref-type="fig"}). The sparse transduction achieved using sindbis viral transfer in the SNc ([Figure 3f](#fig3){ref-type="fig"}) suggests that GluD1^VR^ expression suppresses mGlu1/5-gated currents in DA neurons via a cell-autonomous effect. These results indicate that mGlu1/5-gated currents in DA neurons critically depend on ion flow through GluD1 channels.

Hence, our pharmacological, biophysical and genetic disruption analyses show that native GluD1 channels are opened by activation of mGlu1/5 and are a key determinant of the sEPSC and the *I*~DHPG~ in DA neurons.

GluD1 controls the burst firing of DA neurons *in vivo*
-------------------------------------------------------

The firing of DA neurons *in vivo* consists in either single spikes or bursts of action potentials.^[@bib56]^ It is known that activation of mGlu1/5 promotes bursting of DA neurons in brain slices and increases their bursting frequency *in vivo*.^[@bib26],\ [@bib27],\ [@bib28]^ We thus explored the consequences of genetic disruption of the GluD1 channel on the firing of DA neurons *in vivo* using juxtacellular recordings in anesthetized mice. DA neurons were identified from their electrophysiological hallmarks^[@bib56]^ ([Supplementary Methods](#sup1){ref-type="supplementary-material"}). Furthermore, some recorded neurons were electroporated with neurobiotin for *post hoc* immunohistochemistry. Among all recorded neurons, those successfully labeled for neurobiotin in the SNc (*n*=27/124) and the VTA (*n*=43/230) were all TH-positive ([Figures 4b and d](#fig4){ref-type="fig"}, [Figure 5c](#fig5){ref-type="fig"} and [Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}), assessing a low misidentification rate of DA neurons.

We first compared the firing pattern, measured as spike frequency and percentage of within burst (%SWB), of DA neurons from both the SNc and the VTA in GluD1^−/−^ spikes and WT mice ([Figures 4a and c](#fig4){ref-type="fig"} and [Supplementary Figure S7A](#sup1){ref-type="supplementary-material"}). The spiking frequency of DA neurons recorded in WT mice (SNc: 2.6±0.1 Hz, *n*=45; VTA: 3.4±0.3 Hz, *n*=45) exhibited a modest but significant decrease in GluD1^−/−^ mice (SNc: 1.9±0.1 Hz, *n*=39, *P*\<0.001; VTA: 1.9±0.1 Hz, *n*=45, *P*\<0.001; [Figures 4a and c](#fig4){ref-type="fig"}). Strikingly, the typical burst firing of DA neurons observed in WT mice (SNc: 6.2±1.7%SWB, *n*=45; VTA: 13.1±3.1%SWB, *n*=45) was abolished in GluD1^−/−^ mice (SNc: 0.2±0.1%SWB, *n*=39, *P*\<0.001; VTA: 1.6±0.6%SWB, *n*=45, *P*\<0,001; [Figures 4a and c](#fig4){ref-type="fig"}). Hence, GluD1 deletion hampers burst firing of DA neurons, consistent with above observations on the critical role of GluD1 in mGlu1/5-dependent currents and with the involvement of mGlu1/5 in the burst firing of these neurons.^[@bib26],\ [@bib27],\ [@bib28]^

We next tested the dependence of burst firing on the GluD1 channel pore by co-expressing the dominant-negative GluD1^VR^ mutant and GFP in DA neurons via injection of a lentiviral vector in the SNc or VTA of WT mice ([Figures 4b and d](#fig4){ref-type="fig"}). All of the recorded neurons successfully labeled for neurobiotin in the SNc (*n*=14/40) and the VTA (*n*=10/71) of injected mice were both GFP- and TH-positive ([Figures 4b and d](#fig4){ref-type="fig"}). We found that expression of GluD1^VR^ had no significant effect on the firing rate of DA neurons (SNc: 2.6±0.2 Hz, *n*=40, *P*=0.93; VTA: 2.9±0.1 Hz, *n*=71, *P*=0.09; [Figures 4a and c](#fig4){ref-type="fig"}), but abolished the burst firing of DA neurons in both the SNc (0.3±0.1%SWB, *n*=40, *P*\<0,002) and the VTA (0.6±0.2%SWB, *n*=71, *P*\<0,001; [Figures 4a and b](#fig4){ref-type="fig"} and [Supplementary Figure S7A](#sup1){ref-type="supplementary-material"}). Similar results were obtained in our subsets of neurobiotin-labeled control and GluD1^VR^-expressing DA neurons (SNc: *n*=13 and 14, VTA: *n*=15 and 10, respectively; [Figures 4b and d](#fig4){ref-type="fig"}) for spiking frequency (SNc control vs GluD1^VR^: 2.5±0.2 vs 2.0±0.2 Hz, *P*=0.07; VTA control vs GluD1^VR^: 3.7±0.8 vs 2.9±0.4 Hz, *P*=0.07) and burst firing (SNc control vs GluD1^VR^: 10.4±4.6 vs 0.04±0.03%SWB, *P*\<0,01; VTA control vs GluD1^VR^: 14.5±7.5 vs 0.2±0.1%SWB, *P*\<0,05). Conversely, transduction of VTA DA neurons with a control lentivirus expressing GFP alone did not significantly alter their firing rate (3.0±0.3 Hz, *n*=23, *P*=0.6) or burst firing (13.8±5.4%SWB, *P*=0.9; [Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). Hence, local GluD1^VR^ expression in WT mice and global GluD1 deletion in GluD1^−/−^ mice similarly hamper DA neuron burst firing, pointing to a cell-autonomous effect of GluD1 genetic disruption on DA neuron functions.

We assessed the cell-autonomous nature of GluD1^VR^ effects on DA neurons using injection of Cre-dependent lentiviral vectors encoding both GluD1^VR^ and GFP, or GFP alone (control), in the VTA of DAT-Cre mice. Selective expression of GluD1^VR^ in VTA DA neurons did not significantly change firing frequency as compared to control (2.8±0.2 vs 3.2±0.2 Hz, *n*=28 vs 41, respectively; *P*=0.2) but abolished burst firing (0.2±0.1 vs 11.7±2.9%SWB, *P*\<0.001; [Figures 5a and b](#fig5){ref-type="fig"} and [Supplementary Figure S7B](#sup1){ref-type="supplementary-material"}). Neurobiotin-labeled cells were all GFP- and TH-positive and yielded similar results (frequency: 2.7±0.4 vs 3.2±0.3 Hz, *P*=0.1; burst: 16.7 ±10.2 vs 0.01±0.01%SWB, *P*\<0.01; *n*=7 and 7 for control and GluD1^VR^, respectively; [Figures 5c and d](#fig5){ref-type="fig"}). These observations indicate that the burst firing of DA neurons depends on ion flow through GluD1 channels expressed by these neurons, as observed above for mGlu1/5-dependent currents.

Our results show that GluD1 channels are a key determinant of the burst firing of DA neurons *in vivo* and suggest that GluD1 alterations can impair dopaminergic functions.

Discussion
==========

We probed the existence of a functional coupling between mGlu1/5 and GluD1, and addressed its role in the sEPSC and the firing pattern of DA neurons. Our data indicate that the activation of mGlu1/5 triggers the opening of GluD1 channels and that these channels are essential to the sEPSC of DA neurons in midbrain slices and to the spontaneous burst firing of these neurons *in vivo*. These results establish a causal link between *GRID1* gene alteration and dopaminergic dysfunction.

We found that the *I*~DHPG~ obtained in HEK cells co-expressing mGlu1/5 and GluD1 is abolished by the mGlu1/5 antagonist AIDA and the GluD pore blocker NASPM, is prevented by the dominant-negative GluD1^VR^ dead pore mutant, and is reduced by the GluD inhibitor D-serine. Moreover, mGlu1-5 co-immunoprecipitate with GluD1, and activation of other Gq-coupled receptors fail to induce GluD1-dependent currents in HEK cells. These observations show that mGlu1/5 activation triggers the opening of GluD1 channels in HEK cells, and suggest that this functional coupling depends on physical interaction between mGlu1/5 and GluD1. The lower potency of the above GluD antagonists on constitutively open GluD1 channel mutants^[@bib51]^ suggests that such mutations alter the pharmacological profile of GluD1. Conversely, the voltage-dependence and pharmacological properties of the mGlu1-dependent GluD1 current closely resemble those described for GluD2,^[@bib12]^ indicating that current reversal at \~0 mV, inward rectification at positive potential, as well as inhibition by NASPM and D-serine are fingerprints of the GluD channel family. Hence, our results de-orphanize GluD1 and indicate that both members of the GluD channels family are gated by mGlu1/5 activation and share common biophysical and pharmacological properties.

GluD1 is widely expressed in the brain^[@bib16],\ [@bib17]^ but its cellular distribution in the midbrain is unknown. We found that the GluD1 mRNA is expressed in single DA neurons together with the TH and the mGlu1/5 mRNAs. The GluD2 mRNA is also detected in single DA neurons, albeit at a lower frequency. Expression of GluD1 protein in DA neurons is assessed by our immunohistochemical experiments, and earlier reports established the presence of both mGlu1 and mGlu5 proteins in these neurons.^[@bib25]^ We also found that GluD1 is localized at the postsynaptic density of excitatory synapses in DA neurons, as observed at hippocampal and cerebellar synapses.^[@bib16],\ [@bib17]^ These results show that GluD1 is present at excitatory postsynaptic sites in midbrain DA neurons and is co-expressed with mGlu1/5, consistent with a role of GluD1 in mGlu1-5-dependent synaptic excitation of these neurons.

The mGlu1/5-dependent currents in DA neurons are closely similar to those carried by GluD channels in HEK cells. Indeed, both the *I*~DHPG~ and the slow EPSC reverse at \~0 mV, inwardly rectify at positive potentials, and are suppressed by AIDA, NASPM or expression of GluD1^VR^. The prominent involvement of GluD1 in both currents is confirmed by their strong reduction in GluD1^−/−^ mice. The non-significant decrease of mGlu1/5-dependent currents in GluD2^HO/HO^ mice may indicate that GluD2 homomers or GluD1-2 heteromers have a minor contribution to these currents, consistent with detection of the GluD2 mRNA in single DA neurons and its low abundance outside the cerebellum.^[@bib16]^ Earlier reports provided pharmacological evidence for the involvement of transient receptor potential canonical channels in mGlu1/5-dependent currents of DA neurons.^[@bib29],\ [@bib57]^ This is reminiscent of the slow EPSC in cerebellar Purkinje cells that reportedly depends on both transient receptor potential canonicals and GluD2, which both belong to a complex also comprising mGlu1.^[@bib12],\ [@bib14],\ [@bib58],\ [@bib59]^ In the present case, the close resemblance of mGlu1/5-dependent currents in DA neurons and in HEK cells indicates that GluD1 is the major ion channel underlying these currents, but does not rule out a contribution of transient receptor potential canonical channels. GluD2 acts as a trans-synaptic scaffold through the interaction of its N-terminal domain with the presynaptic terminal.^[@bib60],\ [@bib61]^ Several observations indicate that disruption of such trans-synaptic scaffolding, which has not been reported for GluD1, is unlikely to be the cause of slow EPSC suppression upon GluD1 genetic inactivation. Indeed, (i) AMPA and NMDA components of fast EPSCs are not significantly altered in GluD1^−/−^ mice, (ii) in our Sindbis viral transduction experiments, mGlu1-5 currents are hampered by the rapid, sparse expression of GluD1^VR^ whose N-terminal domain is intact, and (iii) the *I*~DHPG~, which does not rely solely on synaptic GluD1, is similarly hampered by genetic inactivation. Hence, our results demonstrate that GluD1 is a critical determinant of slow glutamatergic transmission onto DA neurons and point to the direct involvement of the GluD1 pore in the postsynaptic current.

We found that the spontaneous burst firing of DA neurons *in vivo* is virtually abolished in anesthetized animals upon genetic inactivation of GluD1. The overall firing frequency of these neurons is almost unchanged upon local expression of GluD1^VR^ in the SN/VTA or selective expression of GluD1^VR^ in VTA DA neurons, but is significantly reduced by approximately one third in GluD1^−/−^ mice, beyond the decrease expected from burst suppression (6--13%SWB in WT mice). This suggests that GluD1 controls the transition to burst firing via a cell-autonomous effect in DA neurons, whereas changes of the overall firing frequency in GluD1^−/−^ mice may reflect larger scale circuit dysfunctions involving other brain structures where molecular alterations reportedly occur in GluD1^−/−^ mice.^[@bib7],\ [@bib8],\ [@bib16],\ [@bib17]^ Our data further suggest a causal link between the GluD1-dependent slow EPSC and the burst firing of DA neurons, consistent with the involvement of mGlu1-5 in both phenomena.^[@bib26],\ [@bib27],\ [@bib28],\ [@bib30]^ Although the transition to burst firing relies on multiple inputs and intrinsic conductances,^[@bib20],\ [@bib21]^ the slow EPSC appears well-suited as a trigger of bursting that converts high frequency excitatory inputs into a long-lasting depolarization susceptible to enhancement or decrease upon integration of other inputs. Our results thus show that GluD1 critically controls the burst firing of DA neurons *in vivo* and indicate that this control results from the key contribution of GluD1 channels to the slow EPSC of these neurons.

Schizophrenia is characterized by episodic 'positive' symptoms like delusions and psychosis, and/or persistent 'negative' symptoms, such as social withdrawal and cognitive impairments. The 'dopamine hypothesis' of schizophrenia postulates that DA neuron firing and neurotransmission dysfunction^[@bib22],\ [@bib23]^ underlies these behavioral abnormalities. This hypothesis is based on the treatments given to patients but also on neurophysiological evidence. Indeed, patients with schizophrenia show reduced midbrain activation and mesocortical connectivity during reward processing,^[@bib62],\ [@bib63]^ consistent with alterations of DA neuron firing pattern. Likewise, an imbalance between tonic and burst firing of DA neurons has been linked to alterations of brain circuits and behaviors in a mouse model of schizophrenia.^[@bib24]^ However, an alternative explanation of the pathology is the 'glutamate dysfunction' hypothesis, originally based on the observation that intoxication with the glutamate receptor antagonist phencyclidine mimics schizophrenic symptoms.^[@bib18]^ Our work on the role of GluD1 in glutamate transmission onto DA neurons underlines the strong interconnection between glutamate and DA transmission abnormalities. By showing that genetic disruption of GluD1 hampers the burst firing of DA neurons, we provide an explanation of how genetic alterations of the *GRID1* gene can impair glutamate transmission and lead to DA dysfunctions that are relevant for schizophrenia.
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![Activation of mGlu1 triggers the opening of GluD1 channels in HEK cells. (**a**) Bath application of DHPG (100 μ[M]{.smallcaps}) induced a slow inward current in cells co-expressing mGlu1 and GluD1, but not in cells expressing either mGlu1 or GluD1 alone. (**b**) Example of *I/V* curve of the DHPG-induced current exhibiting a reversal potential around 0 mV and inward rectification at positive potentials. (**c**,**d**) The DHPG-induced current was reduced by D-serine (10 m[M]{.smallcaps}) and almost abolished by NASPM (100 μ[M]{.smallcaps}). (**e**) Co-expression of the dominant-negative GluD1^VR^ dead pore mutant with mGlu1 and WT GluD1 dose-dependently reduced the DHPG-induced current. (**f**) Correct targeting of recombinant proteins at the plasma membrane. DHPG, 3,5-dihydroxyphenylglycine; NASPM, naphtyl-acetyl spermine; WT, wild type.](mp2017137f1){#fig1}

![GluD1 is co-expressed with mGlu1/5 in DA neurons. (**a**) Fluorescence micrographs of the SNc and VTA showing diffuse GluD1 immunostaining of somata and processes of DAT-positive DA neurons. Immunostaining almost disappeared in GluD1^−/−^ mice. Scale bar: 100 μm. (**b**) Electron micrographs of the SNc showing immunoparticles for GluD1 (arrowheads) and TH (arrows), as detected using a double-labeling post-embedding immunogold method. GluD1 immunoparticles were detected along the postsynaptic density of dendritic shafts (Den) of TH-labeled DA neurons, establishing asymmetrical synapses with axon terminal (at). No GluD1 immunoparticles were detected in GluD1^−/−^ mice, as highlighted by open arrowhead pointing to postsynaptic density of a TH-labeled neuron. Scale bars: 0.5 μm. (**c**) Characterization of a DA neuron from the SNc typically exhibiting long duration action potentials and spontaneous pacemaker firing at low rate. This biocytin-filled neuron (Bio) was TH-immunopositive (scale bar: 20 μm). (**d**) RT-PCR analysis of a single DA neuron detected expression of TH, mGlu1, mGlu5, GluD1 and GluD2 upon agarose gel electrophoresis of PCR products (ΦX *Hae*III molecular weight marker). Summary of single-cell RT-PCR data obtained in SNc DA neurons is given below the agarose gel picture. (**e**,**f**) The mGlu1/5 antagonist AIDA (150 μ[M]{.smallcaps}) prevented the DHPG-induced current and the sEPSC triggered by local electrical stimulation in DA neurons. AIDA, 1-aminoindan-1,5-dicarboxylic acid; DA, dopamine; RT-PCR, real-time PCR; sEPCS, slow excitatory postsynaptic current; SN, substantia nigra; SNc, SN pars compacta; VTA, ventral tegmental area.](mp2017137f2){#fig2}

![GluD1 channels mediate mGlu1/5-dependent currents in DA neurons. (**a**,**b**) The sEPSC and the *I*~DHPG~ of SNc DA neurons were strongly reduced in GluD1^−/−^ mice, but were not significantly altered in mice bearing a deletion of the GluD2 gene (GluD2^HO/HO^). (**c**) In the VTA, GluD1 deletion also hampered the sEPSC (right panels) of DA neurons identified from their long duration action potentials, spontaneous pacemaker firing at low rate and TH immunoreactivity (left panels). Traces above fluorescence pictures stem from recording of the biocytin-filled cell indicated by an arrow. (**d**) Application of the GluD channel blocker NASPM (100 μ[M]{.smallcaps}) almost abolished the sEPSC and the *I*~DHPG~ in DA neurons of the SNc. (**e**) *I/V* curves of the sEPSC and the *I*~DHPG~ recorded at different preset potentials in DA neurons of the SNc, as exemplified by superimposed traces in left panels. (**f**) Fluorescence pictures show histological analysis of a GFP-positive DA neuron recorded 20 h after injection of a Sindbis virus co-expressing GluD1^VR^ and GFP in the SNc of a WT mouse and labeled with biocytin (Bio). Note the sparse transduction achieved using sindbis viral transfer in the SNc. The sEPSC and the *I*~DHPG~ were largely reduced in SNc DA neurons co-expressing GluD1^VR^ and GFP compared to DA neurons transduced with a control Sindbis virus expressing GFP alone. DA, dopamine; NASPM, naphtyl-acetyl spermine; sEPCS, slow excitatory postsynaptic current; SNc, SN pars compacta; SNR, substantia nigra pars reticulata; VTA, ventral tegmental area; WT, wild type.](mp2017137f3){#fig3}

![GluD1 controls the burst firing of DA neurons *in vivo*. (**a,c**) Examples of spontaneous spike firing patterns (left panels) and corresponding histograms of ISI (middle panels, red dotted lines indicate the limits of burst onset \<80 ms and termination \>160 ms) obtained from DA neurons recorded in GluD1^+/+^ and GluD1^−/−^ mice and in WT mice injected with a lentivirus co-expressing GluD1^VR^ and GFP in the SNc or VTA. Right panels show the mean spike frequency and %SWB of recorded DA neurons. Note that burst firing of DA neurons is virtually abolished by global (GluD1^−/−^) or local (GluD1^VR^) genetic disruption of GluD1. (**b,d**) Left panels: Histological analysis of virally transduced DA neurons recorded 4--6 weeks after injection of lentivirus LV-PGK-GluD1V617R-ires-GFP and filled with neurobiotin. DA, dopamine; IF, interfascicular nucleus; IPN, interpeduncular nucleus; ISI, interspike intervals; ml, medial lemniscus; PN, paranigral nucleus; RMC, red nucleus; SNc, SN pars compacta; SNR, substantia nigra pars reticulata; VTA, ventral tegmental area; WT, wild type; %SWB, percentage of spikes within burst. Right panels: same analyses as in (**a**,**c**) restricted to neurobiotin+/TH+ (GluD1^+/+^) and neurobiotin+/GFP+/TH+ (GluD1^VR^) recorded neurons.](mp2017137f4){#fig4}

![Selective expression of GluD1VR mutant in DA neurons suppresses burst firing. (**a**) Examples of spontaneous spike firing patterns (left panels) and corresponding histograms of ISI (middle panels) obtained from VTA DA neurons recorded in DAT-Cre mice after injection of a Cre-dependent lentivirus expressing either GFP, or GluD1^VR^ and GFP, in the VTA. (**b**) Mean spike frequency and percentage of spikes within burst of recorded DA neurons. Note that selective expression of GluD1^VR^ in DA neurons abolishes burst firing without significant effect on firing frequency. (**c**) Left: Whole field fluorescence micrographs showing selective expression of GFP in VTA TH+ neurons after viral transduction. Right: histological analysis of virally transduced DA neurons recorded 6 weeks after injection of indicated lentivirus and filled with neurobiotin. The oblique neurobiotin-labeled dendrite in lower left picture belongs to another GFP+/TH+ recorded neuron whose soma is out of field. (**d**) Same analyses as in (**b**) restricted to neurobiotin+/GFP+/TH+ recorded neurons. DA, dopamine; ISI, interspike intervals; VTA, ventral tegmental area;.](mp2017137f5){#fig5}
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